Progress of serum amyloid A in diagnosis and treatment of neonatal infectious diseases
10.3760/cma.j.issn.1673-4408.2022.05.006
- VernacularTitle:血清淀粉样蛋白A在新生儿感染性疾病诊治中的研究进展
- Author:
Yuzi XU
1
;
Wenjing SHI
Author Information
1. 上海交通大学附属第六人民医院儿科 200233
- Keywords:
Neonate;
Infection;
Serum amyloid A;
Inflammatory factor
- From:
International Journal of Pediatrics
2022;49(5):311-314
- CountryChina
- Language:Chinese
-
Abstract:
Neonatal infection related diseases are the main causes of neonatal death and disability.Traditional inflammatory factors, such as peripheral blood leucocyte count, C-reactive protein and procalcitonin play an important role in indicating neonatal infectious diseases.However, its sensitivity, specificity and effectiveness still need to be improved.Many studies have shown that the expression of serum amyloid A(SAA)increase significantly in various infectious diseases of neonates, and it has received more and more attention as a new type of infection-related indicator.This article reviews the research progress on the structural characteristics of serum amyloid A, detection methods and its clinical application in various neonatal infectious diseases, follow-up of disease changes, guidance of antibiotic use and evaluation of prognosis.
